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EnvinmHealhPepe,ct105:928-939(1997). hp//ehikniehs.n&ov Lead is one of the most useful elements in industry but serves no useful function in the human body (1) . Over the past 20 years, it has become increasingly evident that low-level lead exposure resulting in blood lead levels between 10 and 15 pg/dl (0.48-0.72 pmol/l) can lead to deleterious effects, particularly in infants and young children (4. The effects of chronic lead exposure include cognitive and behavioral deficits (3, 4) , high blood pressure, and impaired renal function. Since the late 1970s, there has been a substantial reduction or elimination of environmental sources of lead, including house paint, gasoline, water distribution systems, and lead-soldered food and soft drink cans (4) . Pirkle et al. (5) used the data from the National Health and Nutrition Examination Surveys II and III and found that, between 1976 and 1991, the mean blood lead levels for the U.S. population declined from 12.8 to 2.8 pg/dl (0.61-0.13 pmol/l). As a result, the acceptable blood lead levels, also referred to as threshold for action, have been reduced over the years from <25 pg/dl (1.21 pmol/l) in 1985 to <10 pg/dl (0.48 pmol/l) in 1991, but even the currendy accepted blood lead level of<10 pg/dl (0.48 pmol/l) may be excessive (6) .
The purpose of this review is to summarize the current knowledge of the renal effects of chronic lead exposure in humans. Following a review of nephropathy due to occupational lead exposure, I shall discuss the evidence for lead nephropathy following environmental lead exposure in childhood. Other commonly observed symptoms of chronic lead toxicity, induding hypertension, hyperuricemia, and gout will also be discussed. I shall conclude with a discussion of the currently available laboratory tests for the determination of body lead burden as well as for evaluation of renal tubular effects oflead.
Historical Aspects
Plumbism, or lead poisoning, has been recognized for many centuries and is one of the oldest ailments afflicting humans. Nikander (200 B.C.) was first to describe the symptoms of lead poisoning, which included colic and pallor (7) . The English aristocracy of the 17th and 18th centuries suffered from widespread lead poisoning from consumption of Portuguese wine, transported with submerged lead bars to enhance flavor and to prevent spoilage (8) . Lancereaux (1882) provided the first description of kidney disease and interstitial nephritis by postmortem examination of a lead poisoned artist. Olivier (9) also reported on kidney disease in lead poisoning, but failed to differentiate interstitial from glomerular disease (7). It was not until the late 1920s when an epidemic of chronic nephritis in Queensland, Australia, was linked to childhood lead poisoning that the full spectrum of lead-induced nephropathy became apparent (10) (11) (12) . This was followed by reports of renal disease from the Southeastern United States in individuals consuming lead-contaminated illegally distilled (moonshine) whiskey (13) and in industrial lead workers (14) .
Environmental Lead Exposure
Although many industrial sources of lead have been eliminated, excessive environmental lead exposure continues to be a public health problem. Seventy to 99% of all houses built prior to 1959 have painted-surfaces containing significant amounts of lead (15, 16) . Older housing is also more likely to contain lead plumbing (17) . In the past, lead-based paint was a major source of lead poisoning in children; however, direct ingestion of lead paint is now a much less common occurrence. Ingestion of lead-contaminated dust and water by children has been Reviews * Chronic lead nephropathy identified as a major contributor to lead poisoning (15) . In a recent survey of the District of Columbia, high concentrations of lead were found in soil samples from inner-city areas, and lead-based paint was found to be the main source of lead in soil dust (18) . That lead-contaminated dust is a major determinant of lead concentrations in blood has been confirmed by studies showing a direct relationship between blood lead levels and lead concentrations in the ground (19) . Campbell et al. (20) found a highly significant correlation between lead concentrations in drinking water and blood lead concentrations in 293 people living in Scotland where the water lead levels were >100 pg/l (4.83 pmol/l). An important-current public health concern is continuing high blood lead levels in children and the means to reduce them (15) . Children are more susceptible to the effects of environmental lead than adults because of increased gastrointestinal absorption of lead in children (21) . Adults at highest risk are those exposed to lead fumes or dust in industry (22, 23) .
Lead Nephropathy
An association between lead poisoning and renal disease in humans has been recognized for over a century (8, 12, 24) . The major renal effect of acute lead poisoning is disruption of proximal tubular architecture, with laboratory evidence of disturbances in proximal tubular function (25) (26) (27) (28) (Fig. 1) . Histologic changes include eosinophilic intranuclear indusions in proximal tubular cells consisting of lead-protein complexes, and mitochondrial swelling (29) (30) (31) (32) (33) . Renal manifestations of acute lead poisoning have been well described both in animal models and in humans; these include glycosuria, aminoaciduria (34, 35) , and phosphaturia, collectively representing the Fanconi syndrome (36) (37) (38) . These functional changes are thought to be related to an effect of lead on mitochondrial respiration and phosphorylation (26) . Recent (36) . The renal manifestations of acute lead poisoning are usually reversible after chelation therapy and cessation oflead exposure (26,3. In experimental animals, exposure to high concentrations of lead results in increased glomerular filtration (hyperfiltration) after 3 months of exposure. This is followed by a function; these changes usually disappear with chelation therapy or removal from lead sources. Chronic lead poisoning can affect glomerular function when blood lead levels exceed 60 pg/dl. After an initial period of hyperfiltration, the glomerular filtration is reduced and nephrosclerosis and chronic renal failure ensue. Prolonged lead exposure also interferes with distal tubular secretion of urate, leading to hyperuricemia and gout. Finally, chronic lead exposure may cause hypertension, resulting from vasoconstriction due to the action of lead on the renin-angiotensin system (RAS) and on calcium signaling.
progressive decline in the glomerular filtration rate (GFR) and irreversible renal failure by 12 months (41) (42) (43) . A blood lead level of 60 jig/dl (2.89 pmol/l) appears to be the threshold for proximal tubular injury in both animal and human studies.
In humans, the symptoms resulting from chronic lead poisoning are subtle, and often the patients remain asymptomatic until significant reductions of renal function have occurred. As in experimental animals, chronic exposure to high levels of lead results in irreversible changes in the kidney, including interstitial fibrosis, tubular atrophy, glomerular sclerosis, and ultimately renal failure, which necessitates replacement therapy (26, 28) (Fig. 1) . These changes are nonspecific and common to many other types of renal injury; therefore, increased lead burden must be ascertained and other causes of renal failure ruled out before making a diagnosis of lead nephropathy. Chronic high-dose lead exposure has also been implicated in the development of gout and hypertension (13, 44) .
Whether chronic lead nephropathy exists as a dinical entity has been questioned (45) . Many studies of occupational lead poisoning have not taken into account the coexposure to other toxins such as cadmium. Additionally, the relationship between early markers of renal tubular dysfunction, such as the urinary excretion of low molecular weight proteins or N-acetyl P-D-glucosaminidase (NAG) to subsequent development of renal failure, remains to be determined (46) .
Chronic exposure to high concentrations of lead results in a high incidence of chronic nephropathy (10, (47) (48) (49) (Fig. 2) . There was also a positive correlation between serum P2-microglobulin and blood lead levels in men. The same authors had previously found only (44, 65, 66) . In additional articles, Henderson and Inglis (67) showed that the lead content of bone in subjects between 20 and 49 years of age who were born in Queensland and died of granular contracted kidneys were significantly higher than in subjects without such renal disease. In 1963, Emmerson (68) showed that lead excretion, following EDTA infusion, was consistently elevated in patients with chronic renal disease and a history of childhood lead poisoning, but not in those with renal disease due to other causes. Such observations appear to be confined to Queensland and have not been reported from other parts of the world.
Tepper (69) Lead nephropathy in "moonshine" drinkers. A high incidence of chronic lead nephropathy has been described in "moonshine" drinkers, those who drink illegally distilled whiskey. Typically these individuals have also been reported to suffer from hypertension and hyperuricemia with gout (13, 14, 53, 76, 77 IEp.. E144 children near a lead smelter and"'t'l. In the Southeastern United States, consumption of "moonshine" whiskey, known to be adulterated with lead, has been associated with a high incidence of hypertension, hyperuricemia, and gout (13, 81, 82) . Although hyperuricemia is seen in chronic renal failure, the incidence of gout is much higher in chronic lead nephropathy than in other types of renal failure (28, 83, 84) . In patients with lead nephropathy, there is no evidence of overproduction of uric acid, suggesting that lead may impair the renal tubular secretion of uric acid (65, 82, 85) . To determine the relationship between lead and gout nephropathy, Batuman et al. (86) examined the body lead burden of 44 men with gout, without previous symptoms of lead poisoning, using the EDTA lead mobilization test. Among them, half had chronic Environmental Health Perspectives * Volume 105, Number 9, September 1997 Reviews * Loghman-Adham 400 600 -800
Lead in blood (,ug/l) Figure 3 . Relationship between blood lead levels and urinary excretion of N-acetyl (NAG) adjusted to age (95, 102) . ironmental Health.
The pathogenic mechanisms for leadinduced hypertension remain unclear. iction between the Vascular changes have been shown to occur -hat the mechanism in acute lead poisoning associated with different from that nephropathy (103) . Lead causes increased s Santos et al. (94) responsiveness to cx adrenergic stimulation .rs and 60 control (104) (105) (106) , an augmented and prolonged gher mean diastolic pressor response to norepinephrine stimulathe lead-exposed tion, and reduced effectiveness of isoproin the systolic blood terenol in lowering blood pressure (10/). o groups.
These findings suggest an interaction of concentrations of lead with calcium signaling mechanisms mental sources, has involved in smooth muscle contraction rtension. Harlan et (Fig. 1) (99,108) . Hypertension may also be lationship between the result of lead-induced changes in the using data obtained vasculature, the renin-angiotensin system tional Health and (109) (110) (111) , or in renal ion transport Survey (NHANESprocesses (28 (120, 121) . A more recent and much less invasive test for evaluation of lead burden involves the quantitation of bone lead with in vivo XRF (122) (123) (124) (125) (126) (127) (128) (129) (130) (131) (132) . Measurements taken at the midtibial diaphysis using a K-XRF instrument appear to be very reliable (125) . The lead fluorescent signal is normalized to the coherent scatter signal, which results principally from calcium in bone mineral (125) . Using older equipment, the minimum detection limit of XRF was 25 pg/g (123) . However, this limit has continued to decrease with improvements in technology, with a current sensitivity in the range of 5 pg/g). At present, XRF is not widely available for routine clinical use; however, since it is an accurate and noninvasive means of determining body lead burden, its use will undoubtedly become more widespread.
Tests for Detection (74, (135) (136) (137) (138) (139) (140) . Verschoor et al. (59) , in a study of lead workers with blood lead levels below 60 pg/dl (2.89 pmol/l), found the excretion of NAG to be the most sensitive marker of renal tubular dysfunction. There was, however, only a modest increase in urinary NAG excretion (from 3.0 to 3.7 U/mg creatinine) in workers with the highest blood lead concentrations (>3 pmol/l) compared to those with low (<1 pmol/l) blood lead.
It has been suggested that NAG might be an overly sensitive test because its levels are increased in animals with continuous low-level lead exposure at a time when no other signs of kidney damage are detectable (42, 69) . More recently, the heat-stable isoenzyme of NAG has been used as a marker of lysosomal breakdown in proximal tubular cells (138) . Endo et al. (136) studied 46 lead refinery workers with long-term exposure to lead dust; they found markedly increased urinary NAG activity in workers whose blood lead levels exceeded 80 pg/dl (3.86 pmol/l). In one study in rats, ligandin appeared to be a better indicator of tubular injury because it correlated with changes in tubular morphology (42) . No information is available on ligandin excretion in humans.
Bernard et al. (19) studied children recruited from two schools in the vicinity of a lead smelter, with children from a rural area used as controls. Urinary excretion of retinol binding protein was elevated in children from the polluted areas and correlated with blood lead levels. Urinary P2 microglobulin and urinary NAG were elevated only in children from one of the polluted areas, despite similar blood lead levels between children from these areas.
Cardenas et al. (113) used a battery of more than 20 potential indicators of renal function in 50 workers exposed to lead and in 50 control subjects. The most striking effect of lead was interference with renal synthesis of eicosanoids, resulting in lower excretion of 6-keto-PGF l. Increased urinary NAG activity was also found in lead-exposed workers. The authors found no correlation between urinary NAG and blood lead or zinc protoporphyrin levels or the duration of lead exposure. There was, however, a positive correlation between urinary NAG and urinary cadmium excretion. Fels et al. (141) studied various markers of renal proximal tubule injury in 81 male lead-exposed workers and 45 age-matched controls. The mean blood lead level of leadexposed subjects was 2.03 pmol/l (42 pg/dl), with a mean duration of exposure of 7 years. Urinary 6-keto-PGFI, levels were higher in lead-exposed workers, as were urinary thromboxane B2, urinary PGF2., and PGF2 excretion. These findings appear to be opposite those reported above by Cardenas et al. (113) . Intestinal alkaline phosphatase and brush border antigen (BBA) excretion were also increased in 27% and 16% of subjects, respectively. In a subsequent study of the same subjects, Pergande et al. (142) pmol/l) in controls. Urinary NAG was higher in the lead-exposed group and correlated with blood lead levels and with duration of exposure. In contrast, urinary excretion of two brush border enzymes, y-glutamyltranspeptidase and alanine-aminopeptidase, were not increased in lead exposed workers. In summary, conventional renal function tests are insensitive and cannot detect early signs of renal dysfunction in persons exposed to occupational or environmental lead. Measurement of urinary excretion of a panel of low molecular weight proteins and enzymes provides the most sensitive means to evaluate renal tubular dysfunction after lead exposure. These tests are, however, nonspecific and can be abnormal in persons exposed to cadmium or to other nephrotoxins. Therefore, abnormal values must be correlated with evidence of chronic lead exposure.
Summary and Conclusions
Despite significant reductions in industrial and environmental sources of lead, lowlevel lead exposure remains a major health problem in many countries. Children are particularly susceptible because of their exploratory activity and higher gastrointestinal absorption. Acute lead poisoning in humans and in animal models causes destruction of proximal tubular architecture with functional disturbances, including aminoaciduria, glycosuria, and phosphaturia (Fig. 1) . These changes are reversible after chelation therapy. Recent observations, however, have revealed persistent aminoaciduria and glycosuria up to 13 years after treatment of lead poisoning. Chronic lead poisoning, secondary to occupational exposure or consumption of lead-contaminated illicit alcohol, may result in what has been termed lead nephropathy. The latter seems to develop when blood lead levels exceed a threshold of 60 pg/dl (2.89 pmol/l). Renal histologic changes of chronic lead nephropathy are nonspecific and include interstitial fibrosis, tubular atrophy, and glomerular sclerosis. They lead to progressive and irreversible renal failure often associated with hypertension, hyperuricemia, and gout. The development of gout appears to be a common feature of lead nephropathy and may be the result of a direct effect of lead on urate secretion.
Chronic nephropathy, subsequent to childhood lead poisoning, has been reported from Queensland, Australia. However, studies from the United States have failed to show any such sequelae in children up to 35 years after childhood lead poisoning. Recent longitudinal studies, however, have shown direct correlations between blood lead levels and serum creatinine or blood lead and blood pressure. Lead-induced hypertension can occur in the absence of nephropathy. The mechanisms include vascular changes, increased sensitivity to catecholamines, and an effect of lead on the renin-angiotensin system and on calcium signaling mechanisms, resulting in enhanced vasoconstriction and hypertension (Fig. 1) .
Because >90% of lead is stored in bone, blood lead levels are a poor indicator of total body lead burden. The EDTA lead mobilization test has been used extensively to document increased body lead 
